Prevalence of Cardiac Disease in Asymptomatic Pregnant Females Coming to OPD in Tertiary Care Hospital

Authors

  • Aisha Shahid Department of Gynae & Obs, JPMC, Karachi, Pakistan
  • Nighat Ali Shah Department of Gynae & Obs, JPMC, Karachi, Pakistan
  • Memoona Kashaf Department of Gynae & Obs, JPMC, Karachi, Pakistan
  • Sheerin Department of Gynae & Obs, JPMC, Karachi, Pakistan
  • Faiza Falak Department of Gynae & Obs, JPMC, Karachi, Pakistan
  • Ayesha Sattar Department of Gynae & Obs, JPMC, Karachi, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i7.2260

Keywords:

Asymptomatic pregnancy, cardiac disease, echocardiography, antenatal screening, structural heart disease, rheumatic heart disease

Abstract

Objective: To determine the prevalence of structural cardiac disease among asymptomatic pregnant females presenting to the antenatal outpatient department of a tertiary care hospital. Study Design: Cross-sectional study. Place and Duration of Study: Department of Obstetrics and Gynecology, Jinnah Postgraduate Medical Centre (JPMC), Karachi; conducted over a period of three months from March, 2025 to May, 2025. Methodology: A total of 119 asymptomatic pregnant women aged 15–45 years attending routine antenatal checkups were enrolled using non-probability consecutive sampling. Women with known cardiac history, symptomatic heart disease, multiple pregnancies, or pregnancy-induced complications were excluded. After informed consent, participants underwent clinical screening, ECG, and if required, transthoracic echocardiography performed by an experienced cardiologist. Data on demographics, medical history, and clinical symptoms were collected using a structured questionnaire. Prevalence of cardiac disease was documented and analyzed using SPSS version 20. Results: Structural cardiac abnormalities were detected in 9 women (7.56%), including rheumatic mitral stenosis (n=3), atrial septal defect (n=2), mitral valve prolapse (n=1), mild pulmonary hypertension (n=1), dilated left atrium with reduced EF 30–50% (n=1), and severe tricuspid regurgitation (n=1). Conclusion: This study demonstrates a notable prevalence of undiagnosed structural cardiac disease among asymptomatic pregnant women. Routine antenatal screening using ECG and echocardiography may play a pivotal role in early diagnosis and prevention of adverse maternal and fetal outcomes, especially in high-risk populations. Incorporating cardiac assessment into antenatal protocols in resource-limited settings should be considered a public health priority.

Downloads

Download data is not yet available.

References

1. Kazma JM, van den Anker J, Allegaert K, Dallmann A, Ahmadzia HK. Anatomical and physiological alterations of pregnancy. J Pharmacokinet Pharmacodyn. 2020;47(4):271-285.

https://doi.org/10.1007/s10928-020-09677-1

2. Jee SB, Sawal A. Physiological changes in pregnant women due to hormonal changes. Cureus. 2024;16(3):e55544.

https://doi.org/10.7759/cureus.55544

3. Parrettini S, Caroli A, Torlone E. Nutrition and metabolic adaptations in physiological and complicated pregnancy: focus on obesity and gestational diabetes. Front Endocrinol (Lausanne). 2020;11:611929.

https://doi.org/10.3389/fendo.2020.611929

4. Kotit S, Yacoub M. Cardiovascular adverse events in pregnancy: A global perspective. Glob Cardiol Sci Pract. 2021;2021(1):e202105. https://doi.org/10.21542/gcsp.2021.5

5. Prasad D, Prasad RV, Choudhary MK, Kumari K. Cardiovascular disease in pregnancy and its outcome: A prospective study. J Family Med Prim Care. 2023;12(11):2714-2720. https://doi.org/10.4103/jfmpc.jfmpc_507_23

6. Warner ED, Farhan S, Bierowski M, Sahawneh F, Oliveros E, Pirlamarla P, et al. Trends in cardiovascular complications of pregnancy: A nationwide inpatient sample analysis. Am J Med Sci. 2023;366(5):337-346.

https://doi.org/10.1016/j.amjms.2023.09.001

7. Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular heart disease epidemiology. Med Sci (Basel). 2022;10(2):32.

https://doi.org/10.3390/medsci10020032

8. Choi EY, Kim ES, Kim JY, Song MK, Kim SH, Noh CI. Pregnancy outcomes in patients with structural heart disease: a single center experience. Cardiovasc Diagn Ther. 2021;11(1):81-90.

https://doi.org/10.21037/cdt-20-786

9. Bozkaya VÖ, Oskovi Kaplan ZA, Özgü E, Engin Ustun Y. Screening and evaluation of newly diagnosed cardiovascular diseases in first-trimester asymptomatic pregnant women in a tertiary antenatal care center in Turkey. Anatol J Cardiol. 2020;23(2):99-104. https://doi.org/10.14744/AnatolJCardiol.2019.55267

10. Hameed A, Karaalp IS, Tummala PP, et al. Impact of screening echocardiography in pregnancy. J Am Coll Cardiol. 2020;75(23):2859–2869. https://doi.org/10.1016/j.jacc.2020.04.009

11. Javed M, Fatima M, Rehman A. Prevalence of undiagnosed cardiac disease in pregnant women. Pak Heart J. 2021;54(1):29-33. https://www.pakheartjournal.com/index.php/phj/article/view/22

12. Malik S, Qureshi N, Ahmed K. Echocardiographic screening in asymptomatic antenatal women: Experience from a tertiary hospital in Pakistan. J Ayub Med Coll Abbottabad. 2023;35(1):88-92. https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/11135

13. Aziz W, Bhatti S, Qureshi S, et al. Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women. JACC Adv. 2024;3(12_Part_2):101215.

https://doi.org/10.1016/j.jacadv.2024.101215

14. Kumar S, Prasad D. Prevalence of Cardiac Disease in Asymptomatic Antenatal Women. Int J Obstet Gynaecol Res. 2023;10(1):45-48.

https://www.ijogr.org/html-article/10196

15. Desai DK, Moodley J. Silent cardiac disease in pregnancy. Cardiovasc J Afr. 2020;31(3):153-158.

https://doi.org/10.5830/CVJA-2020-018

16. British Society of Echocardiography. Echocardiography in Pregnancy: Guidelines and Best Practices. 2022. https://bsecho.org

17. Zühlke L, Karthikeyan G, Engel ME, et al. Clinical outcomes in RHD screening: WHF recommendations. Nat Rev Cardiol. 2023;20(6):407–419.

https://doi.org/10.1038/s41569-023-00940-9

18. Magder LS, Varner M, Carpenter M. Cardiovascular risk prediction in pregnancy: outcomes in screened vs. unscreened populations. Obstet Gynecol. 2021;138(4):637–644.

https://doi.org/10.1097/AOG.0000000000004521

19. AbouZahr C, Wardlaw T. Maternal mortality causes and strategies in LMICs. Lancet Glob Health. 2021;9(3):e302–e303.

https://doi.org/10.1016/S2214-109X(20)30599-6

20. Arvind B, Kiran R. Cost-effectiveness of antenatal cardiac screening in India: a modeling approach. BMC Pregnancy Childbirth. 2022;22(1):218.

https://doi.org/10.1186/s12884-022-04532-2.

Downloads

Published

2025-07-15

How to Cite

Shahid, A., Shah, N. A., Kashaf, M., Sheerin, Falak, F., & Sattar, A. (2025). Prevalence of Cardiac Disease in Asymptomatic Pregnant Females Coming to OPD in Tertiary Care Hospital. Indus Journal of Bioscience Research, 3(7), 900-903. https://doi.org/10.70749/ijbr.v3i7.2260